Mirabella Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mirabella Financial Services’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$294K	Sell	1,557 -186	-11%	-$32.5K	0.03%	511
2025 Q4	$296K	Sell	1,743 -105	-6%	-$16.1K	0.03%	462
2025 Q3	$244K	Buy	+1,848	New	+$222K	0.02%	207
2023 Q2	–	Sell	-3,360	Closed	-$492K	–	573
2023 Q1	$492K	Buy	+3,360	New	+$497K	0.07%	218
2022 Q2	–	Sell	-13,797	Closed	-$2.15M	–	589
2022 Q1	$2.15M	Buy	+13,797	New	+$2M	0.24%	80

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Mirabella Financial Services's JAZZ Position: Q1 2026 in Review

Mirabella Financial Services reduced its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, selling an estimated $32.5K and leaving 1,557 shares worth $294K. The position accounts for 0.03% of the portfolio, ranked #511.

Mirabella Financial Services first reported a position in JAZZ in Q1 2022 and has held it in 5 quarters since. The position peaked at $2.15M in Q1 2022. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Mirabella Financial Services held 1,557 shares of Jazz Pharmaceuticals worth $294K as of Q1 2026.
Mirabella Financial Services sold 186 Jazz Pharmaceuticals shares in Q1 2026, an estimated $32.5K.
Jazz Pharmaceuticals made up 0.03% of Mirabella Financial Services's portfolio in Q1 2026, its #511 holding.
Mirabella Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
Mirabella Financial Services's Jazz Pharmaceuticals position peaked at $2.15M in Q1 2022.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.